Lantheus Holdings (Evergreen Theragnostics)

North Billerica, MA (Lantheus HQ); Springfield, NJ (Evergreen Theragnostics)
Program data pending ClinicalTrials.gov matching
Not Assessed
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (1)

Signal Score & Pillar Breakdown

Quality Compliance
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs no verified data
Sponsorsno verified data
ModalitiesRadiopharmaceuticals, Radioligand Therapy, Lu-177, Theranostics, Clinical-stage RLT CDMO manufacturing, SPECT/PET diagnostics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
Insufficient financial data. Score requires company profile or SEC filings.
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
Insufficient capacity data. Score requires company profile with manufacturing site information.
Recent Press1 articles
Broad modality coverage (6 modalities)

Recent News 1 articles

news Wed, 31 Ja
Pharmaceutical Industry Mergers & Acquisitions Roundup - Contract Pharma
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Radiopharmaceuticals CDMOs → Radioligand Therapy CDMOs → Lu-177 CDMOs → Theranostics CDMOs → Clinical-stage RLT CDMO manufacturing CDMOs → SPECT/PET diagnostics CDMOs →